Because IAPP oligomerisation levels were increased in T2D patients without complications in comparison to healthy controls, determination of IAPP oligomers in clinically healthy but obese people might become a tool to identify people at risk to develop T2D. The gene discussed is IAPP; the disease is type 2 diabetes mellitus.